Evidence map›Paper›PMID 38172488›Full record

ArticleGeroScience2024

Longitudinal changes in the functional connectivity of individuals at risk of Alzheimer's disease.

Alejandra García-Colomo, Alberto Nebreda, Martín Carrasco-Gómez, Jaisalmer de Frutos-Lucas, Federico Ramirez-Toraño, Carlos Spuch, María Comis-Tuche, Ricardo Bruña, Soraya Alfonsín, Fernando Maestú

Abstract read
In one paragraph

Article in GeroScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Tracking electrophysiological signatures of Alzheimer's disease: a systematic review of multimodal studies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Dynamic functional connectivity is modulated by the amount of p-Tau231 in blood in cognitively intact participants.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alejandra García-Colomo *Center for Cognitive and Computational Neuroscience, Complutense University of Madrid, 28223, Madrid, Spain. algarc23@ucm.es.ORCID 0000-0003-1817-6007
Alberto Nebreda *Center for Cognitive and Computational Neuroscience, Complutense University of Madrid, 28223, Madrid, Spain.
Martín Carrasco-GómezCenter for Cognitive and Computational Neuroscience, Complutense University of Madrid, 28223, Madrid, Spain. martin.carrasco@upm.es.
Jaisalmer de Frutos-LucasCenter for Cognitive and Computational Neuroscience, Complutense University of Madrid, 28223, Madrid, Spain.
Federico Ramirez-TorañoCenter for Cognitive and Computational Neuroscience, Complutense University of Madrid, 28223, Madrid, Spain.
Carlos SpuchTranslational Neuroscience Research Group, Galicia Sur Health Research Institute (IIS-Galicia Sur), SERGAS-UVIGO, CIBERSAM, Vigo, Spain.
María Comis-TucheTranslational Neuroscience Research Group, Galicia Sur Health Research Institute (IIS-Galicia Sur), SERGAS-UVIGO, CIBERSAM, Vigo, Spain.
Ricardo BruñaCenter for Cognitive and Computational Neuroscience, Complutense University of Madrid, 28223, Madrid, Spain.
Soraya AlfonsínCenter for Cognitive and Computational Neuroscience, Complutense University of Madrid, 28223, Madrid, Spain.
Fernando MaestúCenter for Cognitive and Computational Neuroscience, Complutense University of Madrid, 28223, Madrid, Spain.

Funding

Axencia Galega de Innovación IN607B2021/12Instituto de Salud Carlos III PI20/00937Ministerio de Ciencia e Innovación FJC2020-046183-IMinisterio de Ciencia, Innovación y Universidades FPU18/00517Ministerio de Ciencia, Innovación y Universidades FPU18/05768Ministerio de Ciencia, Innovación y Universidades PRE2019-087612Ministerio de Economía y Competitividad PSI2015-68793-C3-1-RMinisterio de Economía y Competitividad RTI2018-098762-B-C31Programa INVESTIGO TR349V-2022-10000052-00
6 · The paper itself

Abstract

First-degree relatives of Alzheimer's disease patients constitute a key population in the search for early markers. Our group identified functional connectivity differences between cognitively unimpaired individuals with and without a family history. In this unprecedented follow-up study, we examine whether family history is associated with a longitudinal increase in the functional connectivity of those regions. Moreover, this is the first work to correlate electrophysiological measures with plasma p-tau231 levels, a known pathology marker, to interpret the nature of the change. We evaluated 69 cognitively unimpaired individuals with a family history of Alzheimer's disease and 28 without, at two different time points, approximately 3 years apart, including resting state magnetoencephalography recordings and plasma p-tau231 determinations. Functional connectivity changes in both precunei and left anterior cingulate cortex in the high-alpha band were studied using non-parametric cluster-based permutation tests. Connectivity values were correlated with p-tau231 levels. Three clusters emerged in individuals with family history, exhibiting a longitudinal increase of connectivity. Notably, the clusters for both precunei bore a striking resemblance to those found in previous cross-sectional studies. The connectivity values at follow-up and the change in connectivity in the left precuneus cluster showed significant positive correlations with p-tau231. This study consolidates the use of electrophysiology, in combination with plasma biomarkers, to monitor healthy individuals at risk of Alzheimer's disease and emphasizes the value of combining noninvasive markers to understand the underlying mechanisms and track disease progression. This could facilitate the design of more effective intervention strategies and accurate progression assessment tools.

Indexed as

Alzheimer DiseaseFollow-Up StudiesHumansMagnetic Resonance ImagingAlzheimer’s disease riskFunctional connectivityLongitudinalP-tau231, MEG

Identifiers

PMID38172488
PMCPMC11009204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.